Viral Dynamics in vivo: Limitations on Estimates of Intracellular Delay and Virus Decay
β Scribed by Andreas V. M. Herz, Sebastian Bonhoeffer, Roy M. Anderson, Robert M. May and Martin A. Nowak
- Book ID
- 123639951
- Publisher
- National Academy of Sciences
- Year
- 1996
- Tongue
- English
- Weight
- 873 KB
- Volume
- 93
- Category
- Article
- ISSN
- 0027-8424
- DOI
- 10.2307/39569
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Treatment of patients with chronic hepatitis C with recombinant interferon alfa (rIFN-alpha) can cause a decrease of serum transaminases and hepatitis C virus (HCV) RNA. Recent trials evaluating combination therapy of IFN-alpha and ribavirin suggested a potential synergistic effect. From serial meas
recently published data on human immunodeficiency vi-In about 30% to 40% of patients with chronic hepatitis rus type 1 (HIV-1) suggesting that both RNA viruses rep-C, treatment with recombinant interferon alfa (r-IFNa) licate continuously and highly productive in vivo. The causes a decrease of serum